Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation—The J-RHYTHM Registry study design-Reference-Cited by-同舟云学术

Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation—The J-RHYTHM Registry study design

Published:2011-01 Issue:1 Volume:57 Page:95-99
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Atarashi Hirotsugu,Inoue Hiroshi,Okumura Ken,Yamashita Takeshi,Origasa Hideki

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

2. Guidelines for pharmacotherapy of atrial fibrillation;Ogawa;Circ J,2008

3. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation;Yasaka;Intern Med,2001

4. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation;Shen;J Am Coll Cardiol,2007

5. Ethnic differences in cardiovascular drug response. Potential contribution of pharmacogenetics;Johnson;Circulation,2008

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcomes in elderly patients with non-valvular atrial fibrillation and high bleeding risk: subanalysis of the J-RHYTHM Registry;Heart and Vessels;2023-12-16

2. Predictive ability of visit-to-visit blood pressure indices for adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry;IJC Heart & Vasculature;2023-06

3. Impact of heart rate on adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry;IJC Heart & Vasculature;2022-12

4. Impact of Systolic Blood Pressure Time in Target Range on Adverse Events in Patients With Nonvalvular Atrial Fibrillation (from the J-RHYTHM Registry);The American Journal of Cardiology;2022-10

5. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists;Heart and Vessels;2022-01-21